Chitra Hosing - Concepedia

Author

Chitra Hosing

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

Bachanova, Veronika, C Hosing, C M Hosing, C. Hosing, C. M. Hosing, C.M. Hosing, CHITRA HOSING, Chitara Hosing, Chitra Hosing, Chitra M Hosing

875

Publications

21.5K

Citations

H-Index

117

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Baylor College of Medicine The University of Texas Health Science Center at Houston

About

Chitra Hosing is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, transplantation, and cell transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	43	91	5.2K
2	Health Sciences	24	32	1.9K
3	Biomedical Engineering	2	2	279
4	Public Health	1	1	18
5	Applied Physiology	1	1	50

Chitra Hosing

233

Publications

19.4K

Citations

H-Index

Page 1

	Year	Citations
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors Enli Liu, David Marín, Pinaki P. Banerjee, New England Journal of Medicine	2020	2K
Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma John F. DiPersio, Edward A. Stadtmauer, Auayporn Nademanee, Blood	2009	773
Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma Frederick L. Locke, Sattva S. Neelapu, Nancy L. Bartlett, Molecular Therapy	2017	601
Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma Keith Sullivan, Ellen Goldmuntz, Lynette Keyes-Elstein, New England Journal of Medicine	2018	567
Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study Kenneth Micklethwaite, Barbara Savoldo, Carlos A. Ramos, Blood	2013	499
Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells Partow Kebriaei, Harjeet Singh, M. Helen Huls, Journal of Clinical Investigation	2016	494
Cord-Blood Engraftment with Ex Vivo Mesenchymal-Cell Coculture Marcos de Lima, Ian McNiece, Simon N. Robinson, New England Journal of Medicine	2012	472
Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial Philippe Armand, Arnon Nagler, Edie Weller, Journal of Clinical Oncology	2013	437
Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial David Marín, Ye Li, Rafet Başar, Nature Medicine	2024	376
Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab Issa F. Khouri, Peter McLaughlin, Rima M. Saliba, Blood	2008	293

Page 1